Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

2seventy bio, Inc. - Common Stock (NQ: TSVT )

3.920 +0.140 (+3.70%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,243,601
Open 3.790
Bid (Size) 3.310 (1)
Ask (Size) 3.940 (1)
Prev. Close 3.780
Today's Range 3.760 - 3.960
52wk Range 3.010 - 17.56
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stocks That Hit 52-Week Lows On Thursday
  During the session on Thursday, 461 stocks hit new 52-week lows. 
Via Benzinga
The Latest Analyst Ratings for 2seventy bio
Via Benzinga

Performance

YTD
-57.80%
-57.80%
1 Month
-27.00%
-27.00%
3 Month
-61.26%
-61.26%
6 Month
-61.57%
-61.57%
1 Year
-72.12%
-72.12%

More News

Read More
Analyst Expectations for 2seventy bio's Future
Via Benzinga
Where 2seventy bio Stands With Analysts
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Week In Review: Hasten Signs $325 Million Deal For China Rights To PCSK9 Cholesterol Therapy
Via Talk Markets
Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
2seventy Bio's Cost Cuts Prudent But Analyst Says It Induces Lower Confidence In Lead Product
Via Benzinga
2seventy bio Announces Strategic Restructuring to Prioritize Growth of Abecma, Streamline Pipeline Advancement and Preserve Financial Runway
From 2seventy bio, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2023
Via Benzinga
2seventy bio and JW Therapeutics Announce Intent To Expand Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies and Autoimmune Therapies
From 2seventy bio
Via Business Wire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
2seventy bio to Participate in the 2023 Morgan Stanley Global Healthcare Conference
From 2seventy bio, Inc.
Via Business Wire
Around $3.5M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Paysafe, Taylor Devices, SomaLogic And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
2seventy bio Reports Second Quarter Financial Results and Recent Operational Progress
From 2seventy bio, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
2seventy bio to Report Second Quarter 2023 Financial Results on August 14, 2023
From 2seventy bio, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Earnings Scheduled For August 14, 2023
Via Benzinga
2seventy bio to Participate in 2023 Wedbush PacGrow Healthcare Conference
From 2seventy bio
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.